Need an Eye Specialist in DLF Gurgaon? DLF Phase 1 through 5 is home to a large population of senior residents, returning NRIs, and working professionals above 40, a demographic that carries above-average risk for glaucoma, optic nerve disease, and chronic dry eye. Most will see a general eye doctor for glasses or cataracts. Few will receive a subspecialty evaluation until a problem is already advanced.
Dr Shibal Bhartiya is a fellowship-trained eye specialist and Mayo Clinic Research Collaborator at Marengo Asia Hospitals, Gurugram, the closest tertiary eye care facility to the DLF belt. She sees patients for complex eye conditions that require more than a routine check. Known for her structured approach to vision risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.
Glaucoma: The Risk Is Higher Than Most DLF Residents Realise
Several factors make glaucoma risk above average in DLF Gurgaon’s resident profile. Myopia, extremely common in professionals who have spent decades in close work, increases structural vulnerability of the optic nerve. Diabetes and hypertension, both highly prevalent in this age group, are independent glaucoma risk factors. Long-term steroid use, for allergies, skin conditions, asthma, or joint pain, can raise eye pressure silently over months and years.
Glaucoma in Indians also tends to occur at lower pressure values than in Western populations. A normal pressure result does not rule out glaucoma. Optic nerve imaging and visual field testing are the only reliable way to detect it early.
Dr Bhartiya has over 25 years of subspecialty focus on glaucoma, has published over 200 peer-reviewed papers, and edited 28 textbooks on the subject. She does not just manage glaucoma: it is her entire clinical discipline.
Neuro-Ophthalmology: Advanced Investigation Under One Roof
Some vision problems are not caused by the eye at all. Optic nerve disease, intracranial pressure problems, pituitary lesions, and vascular events in the brain can all present first as a vision complaint. These conditions are frequently missed at general eye clinics because the equipment and expertise to investigate them are not available.
Dr Bhartiya is Program Director at the Marengo Asia International Institute of Neuro and Spine. Advanced investigations: MRI brain and orbit, MRA, MRV, carotid Doppler, visual evoked potentials, and ERG, are available within the same facility without referral to another hospital.
Patients who have been told their eyes are normal but whose vision continues to deteriorate should consider a neuro-ophthalmology evaluation.
Dry Eye: Why Self-Treatment Rarely Works
Dry eye is one of the most common complaints among DLF residents, and one of the most poorly managed. Over-the-counter lubricant drops address the symptom, not the cause. The most common underlying problem: meibomian gland dysfunction, where the oil glands in the eyelids stop functioning correctly, does not respond to lubricants alone.
A structured dry eye assessment identifies the exact type and severity of disease. Treatment is then directed at the cause: anti-inflammatory drops for inflammatory dry eye, lid hygiene and warm compresses for meibomian dysfunction, tear film stabilisers for aqueous deficiency. Patients who have tried multiple lubricant brands without success are typically suffering from undiagnosed or undertreated meibomian gland disease.
Children’s Eye Health and Myopia in DLF Gurgaon
Children in DLF Gurgaon are among the highest-risk group for early and rapidly progressing myopia in India. The combination of intense academic pressure, heavy device use, and limited outdoor time accelerates myopic progression from an early age. Children who become myopic before age 10 are at significantly higher lifetime risk of retinal complications, glaucoma, and early cataract.
Myopia control strategies, including specific optical corrections and low-dose atropine, are most effective when started early. Dr Bhartiya also screens children for amblyopia, squint, and colour vision defects. Parents should not wait for a teacher or school nurse to raise a concern before booking a formal eye examination.
Who Consults Dr Bhartiya from DLF Gurgaon
Dr Shibal Bhartiya focuses on early, often-missed changes that routine eye exams may not detect. Apart from patients who need a comprehensive eye evaluation, there is a subset of patients who visit Dr Bhartiya for their specific concerns. These include, but are not limited to the following:
| Patient Profile | Reason for Visit |
|---|---|
| Adults above 40 with risk factors | Glaucoma screening and optic nerve baseline |
| Patients on long-term steroids | Silent pressure elevation check |
| Unexplained or worsening vision loss | Neuro-ophthalmology evaluation |
| Chronic dry eye not responding to drops | Structured diagnosis and targeted treatment |
| Children with screen fatigue or squinting | Myopia assessment and control |
| Patients with existing diagnosis | Second opinion before committing to treatment |
Frequently Asked Questions
Which DLF phases are closest to Marengo Asia Hospitals?
DLF Phase 4 and 5 are approximately 10 minutes by car. DLF Phase 1, 2, and 3 are 15 to 20 minutes via NH-48.
I use steroid nasal spray for allergies. Can this affect my eyes?
Yes. Nasal steroid sprays, skin creams, and inhaled steroids can all raise intraocular pressure in susceptible individuals. A pressure and optic nerve check is advisable if you have used any steroid preparation for more than three months.
What age should my child have their first eye examination?
By age three, or earlier if you notice squinting, one eye turning, or reluctance to focus on near objects. Do not wait for school age.
Is a neuro-ophthalmology appointment different from a regular eye appointment?
Yes. It includes assessment of the visual pathway, optic nerve, visual cortex, and neurological function, not just the eye structures. It often involves additional imaging and takes longer than a routine consultation.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care.
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
1500+ Five Star Patient Reviews Google Business Profile
Upload your reports for a structured review.
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma